HolderBook

TURNSTONE BIOLOGICS CORP (TSBX)

Institutional ownership reported to the SEC as of Q2 2025, across 8 quarters.

23
Reporting holders
$3.0M
Reported value
0.0%
Calls
0.0%
Puts
+0
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
ORBIMED ADVISORS LLC$1.1M3,099,2650.03%8qHELD
FMR LLC$407.1K1,133,9870.00%8qHELD
BML Capital Management, LLC$396.1K1,103,3860.30%2qHELD
TAKEDA PHARMACEUTICAL CO LTD$321.6K895,8241.64%7qHELD
Point72 Asset Management, L.P.$293.3K816,9230.00%8q-7.1%-$22.3K
72 Investment Holdings, LLC$197.4K549,9800.52%8qHELD
CITADEL ADVISORS LLC$75.0K208,8870.00%newNEW
GEODE CAPITAL MANAGEMENT, LLC$46.7K130,0770.00%8q-4.9%-$2.4K
DELTEC ASSET MANAGEMENT LLC$38.1K106,0570.01%newNEW
VANGUARD GROUP INC$30.1K83,9260.00%8q-83.7%-$154.8K
SUSQUEHANNA INTERNATIONAL GROUP, LLP$28.5K79,3050.00%3q+213.4%+$19.4K
HRT FINANCIAL LP$20.0K55,8590.00%2q+362.3%+$15.7K
RENAISSANCE TECHNOLOGIES LLC$16.9K47,1000.00%3q+17.2%+$2.5K
GTS SECURITIES LLC$16.2K45,1630.00%newNEW
XTX Topco Ltd$13.6K37,7860.00%3q+5.7%
NORTHERN TRUST CORP$6.6K18,4050.00%8qHELD
ACADIAN ASSET MANAGEMENT LLC$4.0K16,4300.00%4q-7.9%
Tower Research Capital LLC (TRC)$1.7K4,7410.00%8qHELD
BlackRock, Inc.$3831,0660.00%4q-97.5%-$14.9K
JPMORGAN CHASE & CO$571580.00%8q-19.4%
BANK OF AMERICA CORP /DE/$541500.00%8q-100.0%-$320.9K
BNP PARIBAS FINANCIAL MARKETS$431210.00%3qHELD
UBS Group AG$25710.00%8qHELD

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202523$3.0M8,434,6673470.0%
Q1 202523$4.3M10,393,09532100.0%
Q4 202428$5.5M11,096,4937470.0%
Q3 202424$6.4M11,443,20414100.0%
Q2 202445$33.3M12,708,6731411110.0%
Q1 202440$35.1M13,402,96951970.0%
Q4 202336$33.2M13,040,31921390.0%
Q3 202335$48.0M12,204,27235000.0%